Sultan’s Score: A Novel Predictive Score to Predict Complete Response Following Drug-Eluting Bead Chemoembolization
Open Access
- 2 January 2025
- journal article
- Published by Springer Nature in Cureus
- Vol. 17 (1) , e76822
Abstract
Background: Transcatheter arterial chemoembolization (TACE) is a well-known standard treatment for hepatocellular carcinoma (HCC); however, the effectiveness of this treatment can vary among patients. Objectives: This study aimed to develop a novel imaging-based prediction score (Sultan’s score) to predict complete response after treatment. Methods: From January 2015 to 2021, 41 patients with solitary HCC, admitted at King Saud University Medical City, Riyadh, Saudi Arabia, were treated with drug-eluting TACE (DEBTACE). Clinical data, tumor details, treatment specifics, and outcomes were gathered retrospectively. Sultan's score incorporates five imaging-based elements, namely, well-defined tumor borders, presence of tumor capsule, tumor size, arterial hyper enhancement, and hypertrophic arterial feeder. The cut-off value of Sultan's score was determined by calculating the maximum Youden index using the receiver operating characteristic curve to accurately predict complete treatment response to DEBTACE. Results: Following two DEBTACE sessions, 28 (68.3%) and 13 (31.7%) patients showed complete and partial responses, respectively. The mean ± standard deviation and median (interquartile range) of the Sultan’s score in patients with a complete treatment response were 3.93 ± 0.72 and 4 (4-4), and the corresponding values in patients with a partial response were 2.77 (0.93) and 3 (2-3.5), respectively. A cut-off value of 3.5 for the Sultan’s score had a sensitivity and specificity of 78.6% and 76.9%, respectively, in predicting a complete treatment response. The area under the curve was 0.827 (95% confidence interval: 0.688-0.966). Conclusions: We developed a novel imaging-based scoring system (Sultan’s score) for predicting complete response in patients with HCC following DEBTACE.Keywords
This publication has 27 references indexed in Scilit:
- A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic functionBMC Cancer, 2020
- A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus StatementsLiver Cancer, 2020
- Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolizationWorld Journal of Gastroenterology, 2020
- Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2020
- Radiological appearance of hepatocellular carcinoma predicts the response to trans-arterial chemoembolization in patients undergoing liver transplantationBMC Cancer, 2019
- Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinomaEuropean Radiology, 2015
- Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinomaJournal of Hepatology, 2015
- Retreatment with TACE: The ABCR SCORE, an aid to the decision-making processJournal of Hepatology, 2015
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancerAnnals of Oncology, 2013
- The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinomaHepatology, 2013